Article

University of Michigan Health System expands Kellogg Eye Center

The University of Michigan Health System (UMHS), Ann Arbor, will expand its Kellogg Eye Center, home to the medical school’s department of ophthalmology and visual sciences.

The $120-million project will increase the space for vision research, education, and patient care by 50%, according to the university. The 215,000-square-foot building will replace operating rooms and eye-care clinics located in two buildings. Both the current and new buildings will contain research laboratories.

The new facility also will house the Delores S. and William K. Brehm Center for Type I Diabetes Research and Analysis. The research program aims to accelerate the search for a cure for Type I diabetes. The center is named for the Virginia couple that donated $44 million to the university in November-of which $30 million is designated for new research facilities.

In addition to the Brehm contribution, the department of ophthalmology and visual sciences has raised $10 million in donations. The building also will be partially funded by resources from the UM Hospitals and Health Centers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.